Risk factors for mortality in children with Wilms tumor
Abstract
Background Wilms tumor is the most common renal malignancy in children (95%) and one of the leading causes of death in children, with high mortality rates in developing countries. Identifying risk factors for mortality is important in order to provide early intervention to improve cure rates.
Objective To identify risk factors for mortality in children with Wilms tumor.
Methods We performed a case-control study of children (0-18 years of age) with Wilms tumor admitted to Dr. Sardjito Hospital between 2005 and 2012. The case group consisted of children who died of Wilms tumor, whereas the control group were children who survived. Data were collected from medical records. Statistical analyses using Chi-square and logistic regression tests were done to determine odds ratios and 95% CI of the potential risk factors for mortality from Wilms tumor.
Results Thirty-five children with Wilms tumor were admitted to Dr. Sardjito Hospital during the study period. Nine (26%) children died and 26 survived. Stage ≥III was a significant risk factor for mortality in chidren with Wilms tumor (OR 62.8; 95%CI 5.6 to 70.5). Age ≥2 years (OR 1.4; 95%CI 0.1 to 14.3) and male sex (OR 1.2; 95%CI 0.1 to 10.8) were not significant risk factors for mortality.
Conclusion Stage ≥III is a risk factor for mortality in children with Wilms tumor.Â
References
2. Ali K, Sutaryo S, Purwanto I, Mulatsih S, Supriyadi E, Widjajanto PH, et al. Yogyakarta Pediatric Cancer Registry: an international collaborative project of University Gadjah Mada, University of Saskatchewan, and the Saskatchewan Cancer Agency. Asian Pac J Cancer Prev. 2010;11:131-6.
3. Reinhard H, Furtwangler R, Graf N. Wilms tumor update. Urologe A. 2007;46:143-5.
4. Pastore G, Znaor A, Spreafico F, Graf N, Pritchard-Jones K, Steliarova-Foucher E. Malignant renal tumors incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2103-14.
5. Uba AF, Chirdan LB. Childhood Wilms tumor: prognostic factors in North Central Nigeria. West Afr J Med. 2007;26:222-5.
6. Abuidris DO, Elimam ME, Nugud FM, Elgaili EM, Ahmed ME, Arora RS. Wilms tumor in Sudan. Pediatr Blood Cancer. 2008;50:1135-7.
7. Pizzo PA, Poplack DG. Renal tumors. In: Fernandez C, Geller JI, Ehrlich PF, Hill DA, editors. Pediatric oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2010. pp. 861-85.
8. Warmann SW, Furtwangler R, Blumenstock G, Armeanu S, Nourkami N, Leuschner I, et al. Tumor biology influences the prognosis of nephroblastoma patients with primary pulmonary metastases: results from SIOP 93-01/GPOH and SIOP 2001/GPOH. Ann Surg. 2011;254:155-62.
9. Narkbunnam N. Different approaches in management of Wilms tumor: pre or post operative chemotherapy. Siriraj Med J. 2009;61:274-89.
10. Ganesh S, Vennila JJ, Scholz H. An overview and perspectives of Wilms tumor. Int J Cancer Res. 2011;7:1-7.
11. Yang LL, Li MJ, Zheng ML, Xu S, Tang DX, Han YF. Prognostic factors and outcome of Wilms tumour in a tertiary children’s hospital, Cina. HK J Pediatr. 2009;14:108-14.
12. Corwin EJ. Kanker. In: Yudha EK, Wahyuningsih E, Yulianti D, Paryuni PE, editors. Patofisiologi. 3rd ed. Jakarta: Penerbit Buku Kedokteran EGC; 2009. p. 71-3.
13. Beniers AJ, Efferth T, Fuzesi L, Granzen B, Mertens R, Jakse G. p53 expression in Wilms tumor: a possible role as prognostic factor. Int J Oncol. 2001;18:133-9.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2016-10-03
Published 2016-08-31